Swedish study reports low vision loss risk with GLP-1RAs
1. In this cohort study, glucagon-like peptide-1 receptor agonist (GLP-1RA) use was associated with a higher risk of anterior ischemic ...
Tag: GLP-1 receptor agonists
GLP-1RAs may increase ischemic optic neuropathy risk
1. In this target trial emulation, glucagon-like peptide-1 receptor agonist (GLP-1RA) use was associated with a small increase in the ...
The Scan by 2 Minute Medicine®: celebrity whole-body MRI craze floods clinics, cruise ship hantavirus outbreak prompts global tracing, “Ozempic personality” raises new questions, and TikTok’s “cortisol face” trend drives endocrine workups
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. ...
GLP-1 receptor agonists move from weight loss into the longevity conversation
GLP-1 receptor agonists move from weight loss into the longevity conversation GLP-1 receptor agonists are quickly shifting from niche metabolic ...
Similar neuroprotective effects from sodium-glucose cotransporter-2 inhibitors and dulaglutide
1. In this target trial emulation study of older adult patients with type 2 diabetes, those who received sodium-glucose cotransporter-2 ...
#VisualAbstract Glucagon-Like Peptide-1 Receptor Agonists are Protecting in Type 2 Diabetes Mellitus Patients
Click here to read this article in JAMA Internal Medicine. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be ...
The Scan by 2 Minute Medicine®: Attacking Allergies, Shedding Light on Lung Cancer, New Year New Goals and Unoriginal Ozempic
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. ...
Semaglutide improves cardiovascular outcomes in obese patients without diabetes
1. In this randomized-controlled trial, the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide reduced the risk of cardiovascular death, myocardial infarction, ...
Glucagon-like peptide 1 receptor agonists (GLP-1RAs) prescribed for type 2 diabetes are associated with reduced colorectal cancer (CRC) risk compared to other antidiabetic agents
1. In all patients, there was a 44% reduction in risk of colorectal cancer when using GLP-1RAs as compared to ...
The Scan by 2 Minute Medicine®: Curbing Cravings with Zepbound, Tales of Transplants, New Gonorrhea Treatment, and Preterm Problems
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. ...
